Search Results
Feb 23, 2026, 07:20 ET Veris Residential, Inc. Reports Fourth Quarter and Full Year 2025 Results
improvements, leasing commissions, and capital expenditures, (ii) straight-line rents and amortization of acquired above/below market leases, net, and (iii) other non-cash income, plus (iv) other non-cash charges. Core FFO and Adjusted AFFO are presented solely as supplemental disclosure that the Company's
More news about: Veris Residential, Inc.
Feb 23, 2026, 07:17 ET Natural Grocers® Celebrates Texas Independence Day With a Special Gift and Savings Mar. 2-4, 2026
required to use the $5-off coupon. Must present phone number at checkout to accumulate towards the $25 requirement in one transaction.[iii] Sign up by 2/27/2026 to receive this coupon via email or app. {N}power offers are available only to registered members and are subject to program
More news about: Natural Grocers by Vitamin Cottage, Inc.
Feb 23, 2026, 07:00 ET NG ENERGY ANNOUNCES YEAR-END RESERVES AND RESOURCES AND COMMENCEMENT OF DRILLING OF HECHICERO-1X AT SINU-9
large Contingent resources recoverable volume will assist to get access to future infrastructure for natural gas transportation and treatment; and (iii) the proximity to existing infrastructure for natural gas gathering and compression. The key negative factors are: (i) the long-term sustainability of
More news about: NG Energy International Corp.
Feb 23, 2026, 07:00 ET Stepan Reports Fourth Quarter and Full Year 2025 Results
million of after-tax income related to the previously announced Philippines and Lake Providence, LA asset sales.Table IIIReconciliation of Pre-Tax to After-Tax AdjustmentsManagement uses the non-GAAP adjusted net income
More news about: Stepan Company
Feb 23, 2026, 04:08 ET Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE
statements to the market. Ultragenyx gave created falsely optimistic beliefs for its investors regarding the performance of its drug candidate in its Phase III trial. The Company failed to achieve statistically significant endpoints despite its optimistic communications. Based on these facts, Ultragenyx's public
More news about: DJS Law Group LLP
Feb 23, 2026, 04:06 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
understanding of the effects of its drug candidate on patients with Osteogenesis Imperfecta ("OI"). The Company's failures were revealed by the Phase III ORBIT study in which it failed to achieve a statistically significant reduction in annualized fracture rate ("AFR"). Based on these facts, the Company's
More news about: The Schall Law Firm
Feb 22, 2026, 19:10 ET CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC
products Regulatory Agency (MHRA) for stage III non-small cell lung cancer (NSCLC). This marks the second indication approved for the product in the UK.This approval is based on the GEMSTONE-301 study, a multicenter, randomized, double-blind Phase III trial. Results demonstrated that sugemalimab
More news about: CStone Pharmaceuticals
Feb 21, 2026, 12:50 ET INVESTOR ALERT: CoreWeave, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; and (iii) the foregoing was reasonably likely to have a material negative impact on CoreWeave's revenue.The CoreWeave class action lawsuit alleges
More news about: Robbins Geller Rudman & Dowd LLP
Feb 20, 2026, 21:57 ET Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
Company announced the "results from the Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta" disclosing that both its Phase III Orbit and Cosmic studies failed to demonstrate that setrusumab triggered a statistically significant reduction in annualized fracture rates for patients
More news about: ClaimsFiler
Feb 20, 2026, 21:55 ET CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. - CRWV
severity of the risk that its reliance on a single third-party data center supplier created for its ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; and (iv) as a result, CoreWeave's public statements
More news about: ClaimsFiler
Feb 20, 2026, 21:20 ET INVESTOR DEADLINE: Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
mitigate effects arising from the termination of the Residential Clean Energy Credit pursuant to Internal Revenue Code Section 25D (the "25D Credit"); and (iii) accordingly, Enphase Energy overstated its financial and operational prospects.The Enphase Energy class action lawsuit further alleges
More news about: Robbins Geller Rudman & Dowd LLP
Feb 20, 2026, 16:20 ET SMR Shareholder Alert: Robbins LLP Reminds Investors of the Securities Fraud Class Action Filed Against NuScale Power Corporation
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the class period in fact referred to the purported experience
More news about: Robbins LLP
Feb 20, 2026, 10:26 ET RARE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
Ultragenyx' Phase III Orbit study would fail to achieve a statistically significant reduction in annualized fracture rate ("AFR"), such that the second interim analysis could be performed and presented to the investing public; and (ii) in truth, Ultragenyx' optimism in the Phase III Orbit study's results
More news about: Faruqi & Faruqi, LLP
Feb 20, 2026, 09:59 ET PLUG SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Plug Power (PLUG) Investors of Securities Class Action Deadline on April 3, 2026
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.On October 7, 2025, Plug Power issued
More news about: Faruqi & Faruqi, LLP
Feb 20, 2026, 09:16 ET Space Prize Foundation lanza una iniciativa de equidad educativa que llega a cientos de estudiantes y familias de Brownsville
real."En el Museo de los Niños de Brownsville, creemos que el aprendizaje debe ser accesible para todos los niños y niñas", dijo Felipe Pena III, director ejecutivo de CMB. "Esta colaboración nos permite llegar a cientos de estudiantes y familias que de otra manera no tendrían la oportunidad de
More news about: Children's Museum of Brownsville; Space Prize Foundation
Feb 20, 2026, 09:15 ET AI Takes Flight: Five Companies Advancing Defense and Aerospace Intelligence
Air-breathing System (ATLAS) program, focused on advancing solid fuel ramjet propulsion technology with funding from the U.S. Department of Defense under Title III of the Defense Production Act.STARLAUNCH 1 is being developed as a sub-orbital vehicle designed to support short-duration microgravity missions
More news about: USA News Group
Feb 20, 2026, 09:10 ET INVESTOR DEADLINE: NuScale Power Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience
More news about: Robbins Geller Rudman & Dowd LLP
Feb 20, 2026, 08:46 ET BAE Systems rolls out world-leading CV90 combat vehicle to the Slovak Armed Forces
the region.The CV9035 MkIV is the latest version of the proven infantry fighting vehicle. The Slovak variant is equipped with a 35mm Bushmaster III cannon, an advanced fire control system, and modern digital architecture, as well as an active protection system solution and an integrated advanced
More news about: BAE Systems, Inc.
Feb 20, 2026, 06:20 ET Space Prize Foundation 啟動教育平等計劃，觸及數百名布朗斯維爾學生及家庭
我們的目標就是移除障礙，締造能夠激發好奇的時刻，孕育無限可能。」除了參觀博物館，參與計劃的教師還會收到 Space Prize Foundation 設計的課程教材，用於參觀前後延伸學習，鞏固知識，結合課堂理論與現實探索，確保融會貫通。CMB 執行董事 Felipe Pena III 表示：「Children's Museum of Brownsville 深信，學習之門，應為每位孩子打開。 是次合作讓我們得以接觸成百上千的學生及家庭，他們可能原本沒有機會如此參與非正規的 STEM 教育。 這正好有力證明，社區之間的合作能夠有效地將機會普及到更多層面。」BISD
More news about: Children's Museum of Brownsville; Space Prize Foundation
Feb 19, 2026, 21:26 ET Ecopetrol records 1,944 billion barrels of oil equivalent in proven reserves at the close of 2025, replacing 121% of production, with the highest contribution in the last four years
Chichimene, and Akacias fields; (ii) better operational management in the Rubiales and La Cira–Infantas fields, focused on asset efficiency and value; and (iii) contracts with the ANH2.These results represent the highest reserves replacement achieved in the last four years and reflect the
More news about: Ecopetrol S.A.
Feb 19, 2026, 21:25 ET Ecopetrol publishes measures aimed at ensuring the adequate representation of Shareholders at the Annual General Meeting to be held on March 27th, 2026
2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) ("Ecopetrol" or the "Company") announces that to comply with the provisions of Part III, Title I, Chapter VI of the Legal Basic Circular issued by the Financial Superintendence of Colombia (C.E. 006 of 2025), the Company expects to implement
More news about: Ecopetrol S.A.
Feb 19, 2026, 20:04 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pinterest, Inc. - PINS
reallocating resources to AI-focused roles and teams that drive AI adoption and execution, (ii) prioritizing AI–powered products and capabilities, and (iii) accelerating the transformation of its sales and go-to-market approach." On this news, Pinterest's stock price fell $2.49 per share, or 9.61%,
More news about: Pomerantz LLP
Feb 19, 2026, 20:04 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines - RARE
$10.41 per share, or 25.11%, to close at $31.04 per share on July 10, 2025. Then, on December 29, 2025, Ultragenyx announced that both its Phase III Orbit and Cosmic Studies had failed to "achieve statistical significance against the primary endpoints of reduction in annualized clinical fracture rate
More news about: Pomerantz LLP
Feb 19, 2026, 19:29 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Sale of Endeavor Group Holdings, Inc. Class A Common Stock of Class Action Lawsuit and Upcoming Deadlines - EDR
consideration without any collar or contingent value right and offering only a de minimis dividend to shareholders that they shared with themselves; and (iii) disseminating a misleading Information Statement on January 15, 2025 that spoke in present tense about "fairness" and "best interests" to unaffiliated
More news about: Pomerantz LLP
Feb 19, 2026, 19:29 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Enphase Energy, Inc. and Certain Officers - ENPH
its ability to manage its channel inventory; (ii) Enphase overstated its ability to mitigate effects arising from the termination of the 25D Credit; (iii) accordingly, Enphase overstated its financial and operational prospects; and (iv) as a result, the Company's public statements were materially false
More news about: Pomerantz LLP